Pacific Sun Financial Corp cut its stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report) by 13.2% in the fourth quarter, Holdings Channel reports. The firm owned 2,740 shares of the company’s stock after selling 415 shares during the quarter. Pacific Sun Financial Corp’s holdings in Invesco Pharmaceuticals ETF were worth $226,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Howe & Rusling Inc. bought a new stake in Invesco Pharmaceuticals ETF during the third quarter worth about $48,000. FMR LLC lifted its stake in shares of Invesco Pharmaceuticals ETF by 29.4% in the 3rd quarter. FMR LLC now owns 1,057 shares of the company’s stock valued at $92,000 after acquiring an additional 240 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Invesco Pharmaceuticals ETF by 241.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock valued at $352,000 after acquiring an additional 2,862 shares during the last quarter. Grimes & Company Inc. bought a new position in Invesco Pharmaceuticals ETF during the 4th quarter worth $354,000. Finally, Arete Wealth Advisors LLC acquired a new stake in Invesco Pharmaceuticals ETF during the 3rd quarter worth about $402,000.
Invesco Pharmaceuticals ETF Stock Performance
Shares of NYSEARCA PJP opened at $86.61 on Thursday. Invesco Pharmaceuticals ETF has a fifty-two week low of $75.33 and a fifty-two week high of $89.87. The stock has a market cap of $293.61 million, a price-to-earnings ratio of 21.48 and a beta of 0.61. The firm’s 50-day simple moving average is $84.30 and its 200 day simple moving average is $85.86.
Invesco Pharmaceuticals ETF Company Profile
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Featured Articles
- Five stocks we like better than Invesco Pharmaceuticals ETF
- What is Put Option Volume?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What Are the U.K. Market Holidays? How to Invest and Trade
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report).
Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
